Evidence map›Paper›PMID 31681254›Full record

ArticleFrontiers in microbiology2019

Choline Kinase Emerges as a Promising Drug Target in Gram-Positive Bacteria.

Tahl Zimmerman, Juan Carlos Lacal, Salam A Ibrahim

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Is choline kinase alpha a drug target for obesity?Frontiers in endocrinology · 2024
    Article
  2. Quercetin Is a Novel Inhibitor of the Choline Kinase ofAntibiotics (Basel, Switzerland) · 2022
    Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Tahl ZimmermanFood Microbiology and Biotechnology Laboratory, Food and Nutritional Sciences Program, North Carolina Agricultural and Technical State University, Greensboro, NC, United States.
Juan Carlos LacalDepartment of Oncology, Hospital Universitario de Fuenlabrada, Madrid, Spain.
Salam A IbrahimFood Microbiology and Biotechnology Laboratory, Food and Nutritional Sciences Program, North Carolina Agricultural and Technical State University, Greensboro, NC, United States.
North Carolina Agricultural and Technical State University · USHospital Universitario de Fuenlabrada · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Both nosocomial pathogens, such as

Indexed as

antibioticantimicobialcholine kinasegram-positiveStreptococcus pneumoniae

Identifiers

PMID31681254
PMCPMC6813931
OpenAlexW2970498629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.